Stock listing
NASDAQ:EDSA Edesa Biotech, Inc. Stock
Home listing (NASDAQ) of Edesa Biotech, Inc.
Follow Edesa Biotech, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:EDSA
$2.57 USD -0.13 (-4.8%)
Close on Oct 30, 2026
- Day range
- $2.56 – $2.86 USDOct 30, 2026
- Volume
- 30,628 sharesOct 30, 2026
- Market cap
- $34.72M USDAt the close on Oct 30, 2026 · price × 13.51M shares outstanding
- 52-week range
- $0.72 – $20.32 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $246,425 USDMedian day 39,753 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:EDSA · Home | $2.57 USD | -0.13 (-4.8%) | 30,628 | $2.86 | $2.86 | $2.558 | $2.70 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:EDSA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.57 | -0.13 | -4.8% | $2.86 | $2.86 | $2.558 | 30,628 | |
| $2.70 | +0.14 | +5.5% | $2.55 | $2.82 | $2.55 | 43,636 | |
| $2.56 | -0.07 | -2.7% | $2.64 | $2.64 | $2.485 | 70,684 | |
| $2.63 | +0.04 | +1.5% | $2.62 | $2.72 | $2.57 | 25,665 | |
| $2.59 | -0.18 | -6.5% | $2.71 | $2.74 | $2.545 | 63,800 | |
| $2.77 | +0.01 | +0.4% | $2.71 | $2.918 | $2.67 | 18,142 | |
| $2.76 | -0.09 | -3.2% | $2.89 | $2.99 | $2.749 | 22,690 | |
| $2.85 | +0.03 | +1.1% | $2.87 | $2.93 | $2.70 | 39,305 | |
| $2.82 | +0.04 | +1.4% | $2.81 | $3.025 | $2.81 | 35,515 | |
| $2.78 | +0.21 | +8.2% | $2.57 | $2.918 | $2.57 | 25,039 | |
| $2.57 | -0.10 | -3.7% | $2.68 | $2.77 | $2.52 | 64,000 | |
| $2.67 | +0.02 | +0.8% | $2.62 | $2.79 | $2.54 | 75,800 | |
| $2.65 | -0.20 | -7.0% | $2.84 | $2.84 | $2.62 | 72,600 | |
| $2.85 | -0.09 | -3.1% | $2.89 | $3.09 | $2.82 | 59,700 | |
| $2.94 | -0.57 | -16.2% | $3.56 | $3.56 | $2.87 | 81,600 | |
| $3.51 | -0.15 | -4.1% | $3.61 | $3.76 | $3.49 | 36,500 | |
| $3.66 | -0.24 | -6.2% | $3.96 | $3.96 | $3.66 | 51,400 | |
| $3.90 | +0.18 | +4.8% | $3.77 | $4.01 | $3.77 | 20,100 | |
| $3.72 | -0.19 | -4.9% | $3.91 | $4.00 | $3.72 | 12,800 | |
| $3.91 | +0.05 | +1.3% | $3.80 | $4.22 | $3.80 | 69,900 | |
| $3.86 | -0.15 | -3.7% | $4.01 | $4.01 | $3.81 | 18,400 | |
| $4.01 | -0.20 | -4.8% | $4.15 | $4.16 | $3.91 | 15,500 | |
| $4.21 | +0.65 | +18.3% | $3.57 | $4.27 | $3.51 | 84,600 | |
| $3.56 | -0.09 | -2.5% | $3.59 | $3.73 | $3.47 | 41,200 | |
| $3.65 | -0.36 | -9.0% | $4.04 | $4.04 | $3.64 | 48,200 | |
| $4.01 | -0.02 | -0.5% | $4.04 | $4.10 | $3.97 | 15,500 | |
| $4.03 | +0.06 | +1.5% | $3.90 | $4.15 | $3.90 | 19,600 | |
| $3.97 | -0.10 | -2.5% | $4.02 | $4.09 | $3.97 | 25,500 | |
| $4.07 | -0.04 | -1.0% | $4.02 | $4.20 | $4.02 | 26,000 | |
| $4.11 | -0.03 | -0.7% | $4.17 | $4.24 | $3.99 | 42,000 | |
| $4.14 | 0.00 | 0.0% | $4.03 | $4.14 | $4.01 | 41,400 | |
| $4.14 | +0.27 | +7.0% | $3.93 | $4.20 | $3.91 | 24,800 | |
| $3.87 | -0.25 | -6.1% | $4.08 | $4.12 | $3.84 | 94,400 | |
| $4.12 | -0.02 | -0.5% | $4.18 | $4.35 | $4.06 | 35,000 | |
| $4.14 | -0.09 | -2.1% | $4.28 | $4.44 | $4.03 | 54,200 | |
| $4.23 | -0.43 | -9.2% | $4.70 | $4.84 | $4.23 | 26,500 | |
| $4.66 | -0.06 | -1.3% | $4.80 | $4.90 | $4.64 | 40,200 | |
| $4.72 | -0.01 | -0.2% | $4.79 | $5.10 | $4.72 | 32,000 | |
| $4.73 | 0.00 | 0.0% | $4.69 | $4.91 | $4.69 | 32,000 | |
| $4.73 | -0.03 | -0.6% | $4.72 | $4.97 | $4.72 | 36,400 | |
| $4.76 | 0.00 | 0.0% | $4.74 | $4.87 | $4.69 | 26,200 | |
| $4.76 | -0.02 | -0.4% | $4.81 | $5.05 | $4.76 | 29,800 | |
| $4.78 | +0.04 | +0.8% | $4.78 | $5.01 | $4.61 | 24,100 | |
| $4.74 | +0.12 | +2.6% | $4.70 | $4.94 | $4.45 | 91,700 | |
| $4.62 | +0.02 | +0.4% | $4.65 | $4.93 | $4.50 | 70,600 | |
| $4.60 | -0.34 | -6.9% | $4.97 | $4.98 | $4.60 | 81,200 | |
| $4.94 | +0.49 | +11.0% | $4.50 | $5.10 | $4.40 | 234,800 | |
| $4.45 | +0.05 | +1.1% | $4.39 | $4.75 | $4.28 | 112,000 | |
| $4.40 | -0.03 | -0.7% | $4.45 | $4.60 | $4.12 | 101,500 | |
| $4.43 | -0.33 | -6.9% | $4.50 | $4.95 | $4.17 | 156,200 | |
| $4.76 | -0.99 | -17.2% | $5.19 | $6.00 | $4.50 | 391,900 | |
| $5.75 | +0.04 | +0.7% | $5.71 | $6.00 | $5.61 | 119,800 | |
| $5.71 | +0.06 | +1.1% | $5.60 | $6.30 | $5.60 | 49,100 | |
| $5.65 | +0.30 | +5.6% | $5.36 | $6.67 | $5.36 | 123,200 | |
| $5.35 | -0.08 | -1.5% | $5.69 | $5.89 | $5.35 | 46,000 | |
| $5.43 | +0.13 | +2.5% | $5.37 | $5.72 | $5.30 | 35,100 | |
| $5.30 | -0.22 | -4.0% | $5.46 | $5.56 | $5.30 | 25,900 | |
| $5.52 | +0.28 | +5.3% | $5.31 | $5.61 | $5.25 | 34,100 | |
| $5.24 | -0.03 | -0.6% | $5.37 | $5.70 | $5.17 | 37,000 | |
| $5.27 | +0.22 | +4.4% | $5.10 | $5.78 | $5.10 | 54,700 | |
| $5.05 | -0.12 | -2.3% | $5.11 | $5.30 | $5.03 | 21,900 | |
| $5.17 | -0.19 | -3.5% | $5.30 | $5.82 | $5.03 | 31,400 | |
| $5.36 | +0.13 | +2.5% | $5.09 | $5.64 | $5.09 | 36,200 | |
| $5.23 | +0.12 | +2.3% | $5.09 | $5.30 | $4.83 | 39,100 | |
| $5.11 | -0.14 | -2.7% | $5.26 | $5.29 | $4.77 | 58,600 | |
| $5.25 | -0.11 | -2.1% | $5.29 | $5.50 | $4.92 | 76,300 |
- Ticker
- NASDAQ:EDSA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 15, 2026
Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 27 slides
Latest news
Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study
Oct 15, 2026
Closed $2.67 (+0.8%) on Oct 15, 2026
Edesa Biotech Announces Pricing of $25.0 Million Public Offering
Aug 19, 2026
Closed $4.76 (-17.2%) on Aug 20, 2026
Edesa Biotech Announces Proposed Public Offering
Aug 19, 2026
Closed $4.76 (-17.2%) on Aug 20, 2026
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
Aug 13, 2026
Closed $5.35 (-1.5%) on Aug 14, 2026
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors
Jun 11, 2026
Closed $5.65 (+8.4%) on Jun 11, 2026
Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury
Jun 5, 2026
Closed $5.46 (-23.0%) on Jun 5, 2026
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
May 19, 2026
Closed $11.95 (+32.8%) on May 19, 2026
Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results
May 14, 2026
Closed $13.05 (-10.7%) on May 15, 2026
Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit
Mar 31, 2026
Closed $5.55 (+6.1%) on Apr 1, 2026
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
Mar 26, 2026
Closed $5.86 (-10.8%) on Mar 26, 2026
Financings
Public offering of common shares (or pre-funded warrants) and accompanying common share warrants
Aug 20, 2026
Announced: about US$25M · US$5.5 a share · Warrants at US$7.5 · Guggenheim Securities
Dealers: Guggenheim Securities (lead)
Use of proceeds: General corporate purposes, possibly including working capital, capital expenditures, and research, development and manufacturing expenses
Decks
Investor Presentation (October 2026)
Investor deck · 27 slides · October 2026
Investor Presentation (August 2026)
Investor deck · 27 slides · August 2026
ATS 2026
Conference · 10 slides · May 20, 2026
Investor Presentation (May 2026)
Investor deck · 10 slides · May 15, 2026
Edesa Biotech, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 102 in all · newest Oct 15, 2026 · oldest 2019
- Decks
- 6 decks · latest October 2026
Where Edesa Biotech, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:EDSA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:EDSA | BOATS | United States | USD |
| Tradegate:RBT | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Edesa Biotech, Inc.